Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityAPLS / Apellis Pharmaceuticals, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership657,223 shares
Latest Disclosed Value $ 26,440,081
Citigroup Inc ownership in APLS / Apellis Pharmaceuticals, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 657,223 shares of Apellis Pharmaceuticals, Inc. (US:APLS) valued at $26,440,081 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 622,158 shares of Apellis Pharmaceuticals, Inc.. This represents a change in shares of 5.64% during the quarter. The current value of the position is $26,965,860 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (APLS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 60,000 of underlying shares valued at $2,413,800 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

APLS / Apellis Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 657,223 35,065 5.64 26,440 69.18 0.0057
2026-02-13 2025-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 622,158 177,186 39.82 15,629 55.21 0.0069
2025-11-10 2025-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 444,972 306,521 221.39 10,070 320.24 0.0045
2025-08-11 2025-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 138,451 -278,168 -66.77 2,397 -73.70 0.0012
2025-05-12 2025-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 416,619 224,458 116.81 9,111 48.61 0.0047
2025-02-12 2024-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 192,161 179,999 1,480.01 6,132 1,651.71 0.0036
2024-11-12 2024-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 12,162 -30,507 -71.50 351 -78.61 0.0002
2024-08-12 2024-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 42,669 -219,039 -83.70 1,637 -89.36 0.0010
2024-05-10 2024-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 261,708 175,167 202.41 15,383 196.97 0.0101
2024-02-09 2023-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 86,541 -30,355 -25.97 5,180 16.51 0.0037
2023-12-06 2023-09-30 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 116,896 36,911 46.15 4,447 -38.98 0.0033
2023-11-09 2023-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 116,896 36,911 4,447 0.0013
2023-08-10 2023-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 79,985 -43,422 -35.19 7,287 -10.48 0.0048
2023-05-11 2023-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 123,407 41,307 50.31 8,140 91.73 0.0057
2023-02-09 2022-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 82,100 -15,732 -16.08 4,245 -36.47 0.0034
2022-11-10 2022-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 97,832 -4,128 -4.05 6,682 44.91 0.0048
2022-08-10 2022-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 101,960 75,276 282.10 4,611 240.04 0.0034
2022-05-12 2022-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 26,684 -93,004 -77.71 1,356 -76.04 0.0008
2022-02-10 2021-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 119,688 49,396 70.27 5,659 144.24 0.0030
2021-11-10 2021-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 70,292 -22,436 -24.20 2,317 -60.46 0.0014
2021-08-10 2021-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 92,728 -5,346 -5.45 5,860 39.26 0.0035
2021-05-13 2021-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 98,074 2,888 3.03 4,208 -22.72 0.0027
2021-02-11 2020-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 95,186 85,979 933.84 5,445 1,858.63 0.0032
2020-11-12 2020-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 9,207 -58,578 -86.42 278 -87.44 0.0002
2020-08-12 2020-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 67,785 15,336 29.24 2,214 57.58 0.0017
2020-05-12 2020-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 52,449 -28,587 -35.28 1,405 -43.37 0.0013
2020-02-12 2019-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 81,036 45,113 125.58 2,481 186.82 0.0018
2019-11-08 2019-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 35,923 -11,099 -23.60 865 -27.37 0.0007
2019-08-12 2019-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 47,022 23,547 100.31 1,191 160.04 0.0010
2019-05-13 2019-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 23,475 -27,438 -53.89 458 -31.85 0.0004
2019-02-12 2018-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 50,913 3,386 7.12 672 -20.47 0.0007
2018-11-13 2018-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 47,527 20,301 74.56 845 41.07 0.0008
2018-08-10 2018-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 27,226 27,206 136,030.00 599 0.0006
2018-05-11 2018-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 20 -1,200 -98.36 0 -100.00
2018-02-12 2017-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 1,220 1,220 26 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-12 2025-03-31 13F APELLIS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-12 2024-12-31 13F APELLIS PHARMACEUTICALS COM Call 29,000 925 n/a n/a n/a
2024-08-12 2024-06-30 13F APELLIS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-10 2024-03-31 13F APELLIS PHARMACEUTICALS COM Call 89,700 5,273 n/a n/a n/a
2024-02-09 2023-12-31 13F APELLIS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A APELLIS PHARMACEUTICALS COM Call 30,000 50.00 1,141 -37.38 n/a n/a n/a
2023-11-09 2023-09-30 13F APELLIS PHARMACEUTICALS COM Call 30,000 1,141 n/a n/a n/a
2023-08-10 2023-06-30 13F APELLIS PHARMACEUTICALS COM Call 20,000 -19.68 1,822 10.96 n/a n/a n/a
2023-05-11 2023-03-31 13F APELLIS PHARMACEUTICALS COM Call 24,900 0.81 1,642 28.58 n/a n/a n/a
2023-02-09 2022-12-31 13F APELLIS PHARMACEUTICALS COM Call 24,700 -29.43 1,277 -46.59 n/a n/a n/a
2022-11-10 2022-09-30 13F APELLIS PHARMACEUTICALS COM Call 35,000 525.00 2,391 845.06 n/a n/a n/a
2022-08-10 2022-06-30 13F APELLIS PHARMACEUTICALS COM Call 5,600 -54.10 253 -59.19 n/a n/a n/a
2022-05-12 2022-03-31 13F APELLIS PHARMACEUTICALS COM Call 12,200 620 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F APELLIS PHARMACEUTICALS COM Put 60,000 2,414 n/a n/a n/a
2025-05-12 2025-03-31 13F APELLIS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-12 2024-12-31 13F APELLIS PHARMACEUTICALS COM Put 29,000 925 n/a n/a n/a
2024-08-12 2024-06-30 13F APELLIS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-10 2024-03-31 13F APELLIS PHARMACEUTICALS COM Put 89,700 5,273 n/a n/a n/a
2024-02-09 2023-12-31 13F APELLIS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A APELLIS PHARMACEUTICALS COM Put 30,000 1,775.00 1,141 686.90 n/a n/a n/a
2023-11-09 2023-09-30 13F APELLIS PHARMACEUTICALS COM Put 30,000 1,141 n/a n/a n/a
2023-08-10 2023-06-30 13F APELLIS PHARMACEUTICALS COM Put 1,600 -93.57 146 -91.17 n/a n/a n/a
2023-05-11 2023-03-31 13F APELLIS PHARMACEUTICALS COM Put 24,900 0.81 1,642 28.58 n/a n/a n/a
2023-02-09 2022-12-31 13F APELLIS PHARMACEUTICALS COM Put 24,700 -29.43 1,277 -46.59 n/a n/a n/a
2022-11-10 2022-09-30 13F APELLIS PHARMACEUTICALS COM Put 35,000 2,391 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.